CoChat

Observational Registry of Basal Insulin Treatment ( ORBIT ) in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic drugs: Real‐life use of basal insulin in China

Ji, Linong, Zhang, Puhong, Zhu, Dongshan, Li, Xian, Ji, Jiachao, Lu, Juming, Guo, Xiaohui, Jia, Weiping, Weng, Jianping, Wu, Yangfeng, Yang, Wenying, Zou, Dajin, Zhou, Zhiguang, Pan, Changyu, Gao, Yan, Garg, Satish K. · 2017 · Diabetes, Obesity and Metabolism
Cited by 54

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Aims: To examine treatment patterns following basal insulin ( BI ) introduction in type 2 diabetes mellitus ( T2DM ) patients under real‐world conditions across C hina. Materials and methods: Overall, 18 995 patients inadequately controlled ( HbA1c ≥ 53 mmol/mol [7%]) with oral antihyperglycaemic drugs ( OADs ) and willing to receive BI treatment were registered at 209 hospitals and followed at baseline (visit 1), 3 months (visit 2) and 6 months (visit 3). Type of BI was initiated at physicians’ discretion. Results: Retention with BI therapy at 6 months was 75.6%. Use of long‐acting BI predominated, with insulin glargine accounting for 71%, detemir 13% and Neutral Protamine Hagedorn ( NPH ) insulin 16%. Over 70% of long‐acting users maintained the same initial BI at visit 3, while 40% of NPH users switched treatment and 24.4% of participants initiated BI with prandial insulin. The initial mean (± SD ) dose of BI and total insulin was 0.18 ± 0.07 and 0.25 ± 0.19 IU /kg, respectively, with a mean increase of daily dose by 0.03 and 0.02 IU /kg after 6 months, respectively. Only 56.6% of insulin users reported dose titration at visit 3. Mean HbA1c was 81 mmol/mol (9.6%) at baseline and 57 mmol/mol (7.4%) at 6 months. The frequency of hypoglycaemia was 1.61 and 2.07 episodes/patient‐year at baseline and 6 months, respectively. Conclusions: In real‐world clinical settings, add‐on BI therapy in T2DM patients is associated with significant improvement in glycaemic control without overtly compromising safety related to hypoglycaemia and weight gain. Evolution of insulin treatment regimens varied among patients, but dose titration was suboptimal. More active BI dose titration might further improve glycaemic outcome in patients receiving BI therapy. Video Abstract: A free Video Abstract to accompany this article is available at https://vimeo.com/212655959

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dom.12886

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 54

Metadata

Authors
Ji, L., Zhang, P., Zhu, D., Li, X., Ji, J., Lu, J., Guo, X., Jia, W., Weng, J., Wu, Y., Yang, W., Zou, D., Zhou, Z., Pan, C., Gao, Y., & Garg, S. K.
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2017-03-17
Volume
19
Issue
6
Pages
822-830
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W2573858888
Cited by
54
References
8
FWCI
5.20
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Observational Registry of Basal Insulin Treatment ( ORBIT ) in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic drugs: Real‐life use of basal insulin in China. https://app.cochat.ai/papers/10.1111/dom.12886
The paper
Ji, L., Zhang, P., Zhu, D., Li, X., Ji, J., Lu, J., Guo, X., Jia, W., Weng, J., Wu, Y., Yang, W., Zou, D., Zhou, Z., Pan, C., Gao, Y., & Garg, S. K. (2017). Observational Registry of Basal Insulin Treatment ( ORBIT ) in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic drugs: Real‐life use of basal insulin in China. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.12886

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.